Kaleidoscope.bio

Kaleidoscope didn’t come out of a single 'aha' moment. Rather, it was a series of frustrations that built up, until ignoring them became impossible. Back in my functional genomics days, I was part of a large, collaborative initiative that involved some top tier teams from places like the Karolinska, ETH Zurich, J&J, Novartis, Bayer, and Pfizer. The goal was ambitious: a decentralized approach to drug discovery, where expert teams could work on different pieces and share learnings to de-risk assets before they went into clinical trials. In theory, it made sense. In practice, it was challenging, complex, and often chaotic. Trying to answer even the simplest questions - “have we ever generated this data before?”?-?felt impossible. You had to track down the right person (who may or may not remember the answer), then dig through files, spreadsheets, and emails to find the data. And, more often than not, you’d hit several dead ends before (hopefully) getting your answer. This was happening all around, not just with our team. I remember talking to a colleague of mine who shared how they wanted to analyze sequencing data from a specific patient population, as part of a larger group initiative. They searched everywhere, didn’t find anything internally, so decided to generate + analyze it from scratch. Months and months recruiting participants, collecting samples, and running the experiments. Only after all that work - which cost $200,000+ plus all the human time invested - did they realize the data already existed. It had been pre-processed and was sitting in a freezer. The person who generated it had left the team, and the record of the samples + metadata was buried in some spreadsheet on a shared drive. This wasn’t a one-off mistake. It was happening all the time. That’s when it finally clicked: some of the biggest bottlenecks we are facing in biotech aren’t in the science — they’re in the coordination of science. If this was happening in an important, well-funded strategic initiative between some of the best labs and companies in the world, it was happening everywhere.

Stay in the know—no more, no less. With Kaleidoscope, get updates that are just right, so your team saves time and stays focused on what matters! ?? https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

There was a very distinct moment when I knew I wanted to be a founder. During grad school, I took a leave from grad school to join a biotech startup that had spun out of the Broad Institute. They had just raised a few million dollars and were ramping up to a Series A. I worked directly with the CEO and CTO, and it was the first time I saw what it looked like to build something from scratch. I remember one particular day where I was deep in the weeds with work — checking reference, pulling data, stitching together reports. Nothing particularly exciting. But when I finally looked up, it was 8 PM. I had been working since the morning, without checking the time. Walking home through Kendall Square that night, I remember thinking: if I could get that lost in the unglamorous parts of building a company, this was what I wanted to do with my life. The other piece of the puzzle was who I wanted to build with. That part was obvious. David and Ahmed have been two of my closest friends for well over a decade. We share the same views on what's worth building, what success looks like, and what kind of company we’d be proud to bring to the world. So when the idea for Kaleidoscope.bio came along, all three of us knew it was a no-brainer to jump in.

An interesting trend I’m noticing is an emergence of the ‘scientific PM’ in biotech, and I’m here for it. By ‘scientific PMs’ I mean scientists whose majority or full-time job is PMing, and not scientists magically expected to run all their experiments AND keep the team/data/ship organized. This type of role enables a pretty distinct operating model — one that unlocks quicker turnaround time and faster, better-informed decision-making compared to the traditional, more science-disconnected PMs. Pressures like increasing complexity/heterogeneity of science and expectations around capital efficiency also create environments where scientific PMs can thrive. Some more thoughts here: https://lnkd.in/eW8maA-u

?? Big goals need better planning. Managing company roadmaps and complex research just got easier. With Kaleidoscope Projects, you can seamlessly plan, execute, and track your work—all in one place. ??Map out research & company goals ? Track milestones & keep teams aligned ? Stay on schedule with roll-up dates & visual timelines Watch this quickstart video to see Projects in action, and discover how Kaleidoscope can keep your team aligned and moving forward. ?? Want a personalized walkthrough? Book a demo today! https://lnkd.in/eAtfE_tg #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #projectmanagement #therapeutics

A lot of people I talk to ‘stumbled’ into operational roles. Biotechs should be cultivating this, not letting it happen by accident. Every Life Sciences R&D company is taking on huge technical risk — this is inevitable when you’re developing novel science. What you want to minimize is how much execution risk you’re stacking on top, which comes down to sharp operations. This means conscious prioritization of operations and related roles: program leaders, project managers, etc. It’s both creating space for these roles early enough, and positioning them as strategically essential pillars. That, and making sure your team understands why — these roles are essential in nailing tangible company milestones and outcomes, which ultimately enable that brilliant piece of science to reach the clinic, market, patient, etc. Exploring this (+ giving concrete examples) here: https://lnkd.in/eeDHNDNS

Stay aligned, hit milestones, and accelerate clinical success—Kaleidoscope makes it easy to track and share key inflection points with your team! ??? https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

On a scale from 1-10, how efficient do you think your company is? I had a great conversation with Carina about streamlining?R&D operations, saving money, and staying focused on what really matters. Without an effective system to track key data points and milestones, even the best ideas can lose momentum and stall. If you're in biotech, this conversation covers challenges and practical strategies to keep your projects on track and your organization lean. Check it out here:?https://lnkd.in/eueP8ywb

Your therapeutic designs are cutting edge, your tech stack should be too! Your planning tool can sync data directly, surface it for you to compare and decide, and guide you faster through milestones. Don't wait – move faster today. Learn more: https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics

Reduce downtime and speed up handoffs —Kaleidoscope tracks blockers so your team stays in sync and on schedule ??.? https://lnkd.in/gRaUXM4t #biotech #sciencesoftware #pharma #sciencetools #drugdevelopment #cdmo #therapeutics